Health & Biotech
The ASX stocks hoping to profit from the endless search for an ‘elixir of youth’
Weed Week: Cannabis boom a ‘matter of when, not if’; and NSW to allow residents to grow pot
ASX Health Stocks: Imugene wins ‘intention to grant’ cancer vaccine patent, Phase 2 trial in 2024
PharmAust bolsters leadership as CEO attends global ALS/MND Symposium
ASX Health Stocks: Neuren Pharma to begin Phase 2 clinical trial of children with Pitt Hopkins syndrome
Neurotech to extend Phase 2/3 autism spectrum disorder trial to adults
ASX Health Stocks: Compumedics granted FDA clearance; Botanix receives FDA feedback
ASX Health Winners: Biotechs up 10pc in November, and Janus Henderson’s prediction for 2024
PharmAust completes Phase 1 motor neurone disease trial, applies for Orphan Drug Designation
ASX Health Stocks: Clarity Pharma says its drug could be effective in prostate cancer, shares jump 8pc
‘Best place we’ve ever been’: AdAlta looks to monetise lead asset in 2024
On the rise: Erectile dysfunction nasal spray inventor LTR Pharma firms for ASX and major market disruption
Check Up: Imugene’s oncolytic virus VAXINIA granted FDA’s Fast Track, but how effective is this novel therapy?
ASX Health Stocks: 4DX shares continue ascent after signing a deal with global player, Philips
Dimerix gains on China drug application approval
Melodiol enjoys milestone 2023 as subsidiaries bank profits
Wellnex Life to rise 117pc in next 12 months forecasts Vested Equities
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
